Collegium Pharmaceutical, Inc.COLLNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+77.7%
5Y CAGR+27.2%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+77.7%/yr
Annual compound
5Y CAGR
+27.2%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $187.08M | +10.1% |
| 2024 | $169.90M | +1.8% |
| 2023 | $166.96M | +401.1% |
| 2022 | $33.32M | +89.0% |
| 2021 | $17.63M | -68.7% |
| 2020 | $56.23M | +336.8% |
| 2019 | $-23.75M | -14.8% |
| 2018 | $-20.68M | +72.6% |
| 2017 | $-75.45M | +19.8% |
| 2016 | $-94.08M | - |